Literature DB >> 20964478

Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.

Mariola López1, Vincent Soriano, Alejandra Peris-Pertusa, Norma Rallón, Clara Restrepo, Jose Miguel Benito.   

Abstract

T cell activation plays an important role in driving CD4 depletion during the course of HIV infection. There is scarce information about activation of different T cell subsets in HIV(+) individuals experiencing distinct disease progression. The activation of different CD4(+) and CD8(+) T cell subsets and its contribution to total T cell activation were examined measuring CD38 expression by flow cytometry in 120 HIV-infected individuals and 9 uninfected healthy controls. HIV-infected patients were divided into four groups: 11 elite controllers (EC), 14 viremic controllers (VC), 61 antiretroviral-naive typical progressors (TP), and 34 progressors with viral suppression (VS) under antiretroviral therapy. EC displayed significantly greater activation levels than VS, with a higher contribution of central memory subsets to the activation of total CD8 T cells (p = 0.002). The activation of central memory CD8(+) T cells significantly correlated with viral load in TP regardless of CD4 counts. In contrast with VS, proviral load was undetectable in all EC. Compared to VS, EC display abnormal and higher activation levels of different CD8(+) T cell subsets. Factors other than the size of the viral reservoir should explain the high level of activation of central memory CD8(+) T cells characteristically seen in HIV(+) individuals with spontaneous control of viral replication.

Entities:  

Mesh:

Year:  2010        PMID: 20964478     DOI: 10.1089/aid.2010.0107

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

2.  Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.

Authors:  Sudheesh Pilakka-Kanthikeel; Arheart Kris; Anbalagan Selvaraj; Soumya Swaminathan; Savita Pahwa
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

Review 3.  CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.

Authors:  Michèle Février; Karim Dorgham; Angelita Rebollo
Journal:  Viruses       Date:  2011-05-12       Impact factor: 5.048

4.  Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  AIDS Res Treat       Date:  2012-05-27

5.  An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.

Authors:  Ashley D Olson; Laurence Meyer; Maria Prins; Rodolphe Thiebaut; Deepti Gurdasani; Marguerite Guiguet; Marie-Laure Chaix; Pauli Amornkul; Abdel Babiker; Manjinder S Sandhu; Kholoud Porter
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Disease Progression in HIV-1-Infected Viremic Controllers.

Authors:  Katherine C Groves; David F Bibby; Duncan A Clark; Are Isaksen; Jane R Deayton; Jane Anderson; Chloe Orkin; Andrew J Stagg; Aine McKnight
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

7.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

Review 8.  The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review.

Authors:  Matteo Vassallo; Patrick Mercié; Jacqueline Cottalorda; Michel Ticchioni; Pierre Dellamonica
Journal:  Virol J       Date:  2012-08-27       Impact factor: 4.099

9.  A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes.

Authors:  B Chirullo; R Sgarbanti; D Limongi; I L Shytaj; D Alvarez; B Das; A Boe; S DaFonseca; N Chomont; L Liotta; E Iii Petricoin; S Norelli; E Pelosi; E Garaci; A Savarino; A T Palamara
Journal:  Cell Death Dis       Date:  2013-12-05       Impact factor: 8.469

10.  Evaluation of rapid progressors in HIV infection as an extreme phenotype.

Authors:  Ashley D Olson; Marguerite Guiguet; Robert Zangerle; John Gill; Santiago Perez-Hoyos; Sara Lodi; Jade Ghosn; Maria Dorrucci; Anne Johnson; Mette Sannes; Santiago Moreno; Kholoud Porter
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.